AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 6,588.00
+73.50 (1.13%)
Nov 11, 2026, 1:02 PM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 164.64 billion as of November 10, 2026. Its market cap has decreased by 27.52% in one year.
Market Cap
164.64B
Enterprise Value
159.85B
Revenue
26.02B
Global Rank
n/a
Country Rank
n/a
PE Ratio
92.67
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 164.64B, an increase of 11,254.61%. That is a compound annual growth rate of 21.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 164.64B | -26.91% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Piramal Pharma | 317.59B |
| Wockhardt | 317.28B |
| Alembic Pharmaceuticals | 189.29B |
| Alivus Life Sciences | 180.71B |
| Eris Lifesciences | 171.62B |
| Cohance Lifesciences | 165.66B |
| NATCO Pharma | 158.31B |
| Sudeep Pharma | 132.83B |